Name | tert-butyl 4-(5-formyl-1,3-thiazol-2-yl)piperazine-1-carboxylate |
---|
Density | 1.269g/cm3 |
---|---|
Boiling Point | 437.7ºC at 760 mmHg |
Molecular Formula | C13H19N3O3S |
Molecular Weight | 297.37300 |
Flash Point | 218.5ºC |
Exact Mass | 297.11500 |
PSA | 90.98000 |
LogP | 2.01560 |
Index of Refraction | 1.58 |
HS Code | 2934100090 |
---|
~39% 354587-77-2 |
Literature: F. HOFFMANN-LA ROCHE AG Patent: WO2006/72436 A1, 2006 ; Location in patent: Page/Page column 71 ; |
~89% 354587-77-2 |
Literature: Anandan, Sampath-Kumar; Ward, John S.; Brokx, Richard D.; Denny, Trisha; Bray, Mark R.; Patel, Dinesh V.; Xiao, Xiao-Yi Bioorganic and Medicinal Chemistry Letters, 2007 , vol. 17, # 21 p. 5995 - 5999 |
Precursor 2 | |
---|---|
DownStream 0 |
HS Code | 2934100090 |
---|---|
Summary | 2934100090 other compounds containing an unfused thiazole ring (whether or not hydrogenated) in the structure VAT:17.0% Tax rebate rate:9.0% Supervision conditions:none MFN tariff:6.5% General tariff:20.0% |